19 - 21 February, 2019 | Novotel Hotel, AMSTERDAM, Netherlands

Jean-Yves Bauer


Senior Engineer, MS&T / TLCM / IM-BIOPROCESS
GSK


9:10 AM Identifying the Impact of Implementation: Commercial and Process Implications

- Analyse the impact of SUS implementation in driving forward GSK Vaccines product development
- Examine the commercial realities of implementation: what are the unexpected hurdles to overcome, and
what is the cost?
- Discuss what is next? What is missing from the current solutions and what do manufacturers need to see
from suppliers in their new technologies?


Check out the incredible speaker line-up to see who will be joining Jean-Yves.

Download The Latest Agenda